Literature DB >> 9225271

Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.

R Invernizzi1, C Velasco, M Bramante, A Longo, R Samanin.   

Abstract

The aim of the present study was to compare the effects of citalopram, either alone or combined with 5-HT1A receptor antagonists, on extracellular serotonin levels in brain regions innervated by the dorsal or median raphe nuclei. Using intracerebral microdialysis in awake rats with separate probes in the frontal cortex or dorsal hippocampus, we studied the ability of 8 mg/kg s.c. (-)penbutolol, a beta-adrenoceptor antagonist with antagonist action at 5-HT1A and 5-HT1B receptors, and 0.3 mg/kg s.c. WAY-100635, a selective 5-HT1A receptor blocker, to modify the effect of 1 and 10 mg/kg i.p. citalopram on extracellular serotonin. Both doses of citalopram had more effect on extracellular serotonin levels in the dorsal hippocampus than in the frontal cortex. The effect of 1 mg/kg citalopram was significantly potentiated by (-)penbutolol in the frontal cortex only, but a clear-cut potentiation of the effect of citalopram was seen in both regions at a dose of 10 mg/kg. The effect of 10 mg/kg citalopram was potentiated by WAY-100635 in the frontal cortex but not in the dorsal hippocampus. In a second set of experiments, the combined effect of WAY-100635 and citalopram was studied in the same rat implanted with vertical probes in the striatum and dorsal hippocampus. Citalopram (1 and 10 mg/kg i.p.) raised extracellular serotonin to a similar extent in both regions. However, 0.3 mg/kg s.c. WAY-100635 potentiated the effect of 10 mg/kg citalopram in the striatum but not in the dorsal hippocampus. The results suggest that only a combined blockade of 5-HT1A and 5-HT1B receptors potentiates the effect of citalopram on extracellular concentrations of serotonin in the dorsal hippocampus. The findings may be relevant in designing clinical trials aimed at enhancing the antidepressant action of selective serotonin re-uptake inhibitors by combining them with serotonin receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225271     DOI: 10.1016/s0028-3908(97)00060-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

Review 1.  Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.

Authors:  S Navailles; M Lagière; A Contini; P De Deurwaerdère
Journal:  ACS Chem Neurosci       Date:  2013-04-15       Impact factor: 4.418

2.  Effects of citalopram on dopamine D2 receptor expression in the rat brain striatum.

Authors:  K Kameda; I Kusumi; K Suzuki; J Miura; Y Sasaki; T Koyama
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

3.  Effects of Anodal Transcranial Direct Current Stimulation and Serotonergic Enhancement on Memory Performance in Young and Older Adults.

Authors:  Kristin Prehn; Helena Stengl; Ulrike Grittner; René Kosiolek; Anja Ölschläger; Alexandra Weidemann; Agnes Flöel
Journal:  Neuropsychopharmacology       Date:  2016-08-24       Impact factor: 7.853

4.  Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.

Authors:  G Sacchetti; M Bernini; A Bianchetti; S Parini; R W Invernizzi; R Samanin
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

5.  S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.

Authors:  M Carli; C Balducci; M J Millan; P Bonalumi; R Samanin
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.

Authors:  D T Malone; D A Taylor
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Molecular imaging of serotonin degeneration in mild cognitive impairment.

Authors:  Gwenn S Smith; Frederick S Barrett; Jin Hui Joo; Najlla Nassery; Alena Savonenko; Devin J Sodums; Christopher M Marano; Cynthia A Munro; Jason Brandt; Michael A Kraut; Yun Zhou; Dean F Wong; Clifford I Workman
Journal:  Neurobiol Dis       Date:  2017-05-13       Impact factor: 5.996

8.  Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.

Authors:  Khanh Q Nguyen; Yoshihiro Tohyama; Arata Watanabe; Shu Hasegawa; Ivan Skelin; Mirko Diksic
Journal:  Neurochem Int       Date:  2008-11-27       Impact factor: 3.921

9.  Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study.

Authors:  Rebecca Kerestes; Izelle Labuschagne; Rodney J Croft; Barry V O'Neill; Zubin Bhagwagar; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2008-09-30       Impact factor: 4.530

10.  Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.

Authors:  I Ceglia; S Acconcia; C Fracasso; M Colovic; S Caccia; R W Invernizzi
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.